Dermapharm Holding SE
XETRA:DMP
Income Statement
Earnings Waterfall
Dermapharm Holding SE
Revenue
|
1.1B
EUR
|
Cost of Revenue
|
-416.2m
EUR
|
Gross Profit
|
719.2m
EUR
|
Operating Expenses
|
-518.2m
EUR
|
Operating Income
|
201m
EUR
|
Other Expenses
|
-138.6m
EUR
|
Net Income
|
62.4m
EUR
|
Income Statement
Dermapharm Holding SE
Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||
Revenue |
475
N/A
|
467
-2%
|
487
+4%
|
513
+5%
|
546
+6%
|
572
+5%
|
599
+5%
|
625
+4%
|
661
+6%
|
701
+6%
|
730
+4%
|
746
+2%
|
760
+2%
|
794
+4%
|
814
+2%
|
843
+4%
|
887
+5%
|
943
+6%
|
962
+2%
|
986
+2%
|
1 007
+2%
|
1 025
+2%
|
1 112
+9%
|
1 136
+2%
|
1 157
+2%
|
1 135
-2%
|
|
Gross Profit | |||||||||||||||||||||||||||
Cost of Revenue |
(259)
|
(246)
|
(248)
|
(257)
|
(267)
|
(273)
|
(281)
|
(288)
|
(301)
|
(317)
|
(331)
|
(330)
|
(326)
|
(330)
|
(323)
|
(317)
|
(320)
|
(322)
|
(328)
|
(344)
|
(358)
|
(364)
|
(386)
|
(405)
|
(415)
|
(416)
|
|
Gross Profit |
216
N/A
|
221
+3%
|
239
+8%
|
256
+7%
|
279
+9%
|
300
+7%
|
317
+6%
|
338
+6%
|
360
+7%
|
384
+7%
|
399
+4%
|
416
+4%
|
434
+4%
|
463
+7%
|
491
+6%
|
526
+7%
|
567
+8%
|
621
+9%
|
634
+2%
|
642
+1%
|
649
+1%
|
661
+2%
|
727
+10%
|
731
+1%
|
743
+2%
|
719
-3%
|
|
Operating Income | |||||||||||||||||||||||||||
Operating Expenses |
(124)
|
(131)
|
(141)
|
(157)
|
(175)
|
(185)
|
(212)
|
(227)
|
(248)
|
(262)
|
(268)
|
(289)
|
(302)
|
(321)
|
(342)
|
(342)
|
(333)
|
(325)
|
(329)
|
(365)
|
(380)
|
(377)
|
(457)
|
(483)
|
(520)
|
(518)
|
|
Selling, General & Administrative |
(63)
|
(99)
|
(69)
|
(75)
|
(83)
|
(150)
|
(100)
|
(105)
|
(114)
|
(198)
|
(119)
|
(134)
|
(142)
|
(258)
|
(168)
|
(167)
|
(168)
|
(258)
|
(168)
|
(176)
|
(180)
|
(291)
|
(206)
|
(222)
|
(243)
|
(419)
|
|
Research & Development |
0
|
(7)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(11)
|
|
Depreciation & Amortization |
(15)
|
(16)
|
(18)
|
(22)
|
(24)
|
(24)
|
(37)
|
(41)
|
(47)
|
(46)
|
(49)
|
(49)
|
(48)
|
(44)
|
(51)
|
(51)
|
(51)
|
(45)
|
(57)
|
(84)
|
(85)
|
(51)
|
(104)
|
(99)
|
(106)
|
(86)
|
|
Other Operating Expenses |
(45)
|
(9)
|
(55)
|
(60)
|
(68)
|
(4)
|
(75)
|
(80)
|
(87)
|
(7)
|
(101)
|
(106)
|
(112)
|
(6)
|
(123)
|
(124)
|
(114)
|
(8)
|
(104)
|
(105)
|
(115)
|
(22)
|
(147)
|
(163)
|
(171)
|
(3)
|
|
Operating Income |
92
N/A
|
91
-2%
|
97
+7%
|
99
+2%
|
104
+5%
|
114
+10%
|
106
-7%
|
111
+5%
|
112
+1%
|
122
+9%
|
130
+7%
|
127
-3%
|
132
+4%
|
143
+8%
|
149
+4%
|
184
+24%
|
235
+27%
|
295
+26%
|
305
+3%
|
277
-9%
|
268
-3%
|
283
+6%
|
270
-5%
|
247
-8%
|
223
-10%
|
201
-10%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||
Interest Income Expense |
(4)
|
(2)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(10)
|
(11)
|
(13)
|
(14)
|
(12)
|
(11)
|
(9)
|
(8)
|
(2)
|
(3)
|
(6)
|
(7)
|
(26)
|
(41)
|
(51)
|
(64)
|
(75)
|
|
Non-Reccuring Items |
0
|
(0)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(40)
|
0
|
0
|
0
|
(16)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
(0)
|
(0)
|
(1)
|
0
|
0
|
0
|
(4)
|
|
Pre-Tax Income |
88
N/A
|
88
0%
|
94
+7%
|
96
+2%
|
101
+5%
|
104
+3%
|
102
-3%
|
107
+5%
|
107
+0%
|
110
+3%
|
120
+9%
|
114
-5%
|
118
+3%
|
125
+6%
|
138
+10%
|
175
+28%
|
226
+29%
|
293
+29%
|
301
+3%
|
271
-10%
|
261
-4%
|
216
-17%
|
229
+6%
|
196
-14%
|
158
-19%
|
106
-33%
|
|
Net Income | |||||||||||||||||||||||||||
Tax Provision |
(4)
|
(10)
|
(15)
|
(20)
|
(26)
|
(29)
|
(29)
|
(30)
|
(33)
|
(32)
|
(34)
|
(36)
|
(37)
|
(39)
|
(42)
|
(53)
|
(65)
|
(84)
|
(92)
|
(87)
|
(86)
|
(84)
|
(84)
|
(75)
|
(65)
|
(45)
|
|
Income from Continuing Operations |
84
|
78
|
79
|
76
|
75
|
75
|
73
|
77
|
74
|
78
|
85
|
77
|
81
|
86
|
95
|
123
|
162
|
209
|
210
|
185
|
175
|
133
|
145
|
121
|
93
|
61
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
Net Income (Common) |
22
N/A
|
21
-8%
|
38
+86%
|
50
+31%
|
64
+28%
|
75
+17%
|
73
-3%
|
77
+5%
|
74
-4%
|
77
+5%
|
85
+10%
|
77
-10%
|
80
+4%
|
86
+7%
|
95
+11%
|
123
+29%
|
162
+32%
|
210
+29%
|
211
+1%
|
185
-12%
|
176
-5%
|
134
-24%
|
146
+9%
|
123
-16%
|
95
-23%
|
62
-34%
|
|
EPS (Diluted) |
0.45
N/A
|
0.38
-16%
|
0.72
+89%
|
2.17
+201%
|
1.19
-45%
|
1.41
+18%
|
1.35
-4%
|
1.45
+7%
|
1.38
-5%
|
1.43
+4%
|
1.58
+10%
|
1.42
-10%
|
1.48
+4%
|
1.59
+7%
|
1.76
+11%
|
2.28
+30%
|
3.02
+32%
|
3.89
+29%
|
3.88
0%
|
3.45
-11%
|
3.3
-4%
|
2.49
-25%
|
2.73
+10%
|
2.29
-16%
|
1.76
-23%
|
1.16
-34%
|